Leveraging Administrative Data to Monitor Rituximab Use in 2875 Patients at 42 Freestanding Childrens Hospitals across the United States

摘要

ObjectiveTo describe the pharmacoepidemiology of rituximab use in children and to estimate the frequency of infectious events within a 1-year period after rituximab exposure.